Healthcare | July 06, 2022
Apollo Hospitals integrates cardiovascular risk tool with ConnectedLife digital wellness solutions
The AICVD tool can predict the risk of cardiovascular disease.
The AICVD tool can predict the risk of cardiovascular disease.
_256_384.jpg){kind=logo}
Meets the growing need for US-based API solubility and bioavailability enhancement services
Shanghai Public Health Clinical Center Completed the First Patient Dosing in Clinical Study of PD-L1 Antibody ASC22 in Combination with Chidamide for Functional Cure of HIV Infection
A newly revealed mechanism by Weizmann Institute of Science of ketamine’s action on potassium channels in neurons may lead to improved therapies for depression
This facility will produce higher efficacy products that enjoy greater acceptance and enhanced profit marginsg
Medidata Detect and Rave CTMS Have Improved Study Execution Through Role-Based Monitoring Workflows and Clinical Data Visualization for Hundreds of Customers Across More Than 9,000 Studies
Ex-Azithromycin has shown a growth of 8% and 14% in April 2022 and May 2022 respectively
Becomes first Japanese logistics company to collaborate with EMBALL’ISO, which has a proven track record in vaccine transport
LYNPARZA is approved in the U.S. for patients with HRR gene-mutated mCRPC (BRCA-mutated and other HRR gene mutations)
The ground floor of the formulation development laboratory is focused on solid orals, the first floor on injections, and the second floor houses the analytical lab
Subscribe To Our Newsletter & Stay Updated
